A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients

NCT06569485 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

DLBCL

Interventions

DRUG: Trilaciclib+R-CHOP

Sponsor

Sun Yat-sen University